Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Amedisys Inc (AMED)

Amedisys Inc (AMED)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,274,554
  • Shares Outstanding, K 32,467
  • Annual Sales, $ 1,956 M
  • Annual Income, $ 126,830 K
  • 60-Month Beta 0.90
  • Price/Sales 3.88
  • Price/Cash Flow 37.60
  • Price/Book 10.50

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate 1.27
  • Number of Estimates 8
  • High Estimate 1.40
  • Low Estimate 1.17
  • Prior Year 1.15
  • Growth Rate Est. (year over year) +10.43%

Price Performance

See More
Period Period Low Period High Performance
1-Month
221.78 +1.27%
on 09/24/20
248.96 -9.79%
on 09/02/20
-13.77 (-5.78%)
since 08/24/20
3-Month
190.38 +17.97%
on 06/25/20
248.96 -9.79%
on 09/02/20
+32.59 (+16.97%)
since 06/24/20
52-Week
121.00 +85.61%
on 10/07/19
248.96 -9.79%
on 09/02/20
+92.06 (+69.46%)
since 09/24/19

Most Recent Stories

More News
28.9% Return Seen to Date on SmarTrend Amedisys Inc Call (AMED)

SmarTrend identified an Uptrend for Amedisys Inc (NASDAQ:AMED) on June 18th, 2020 at $185.42. In approximately 3 months, Amedisys Inc has returned 28.93% as of today's recent price of $239.06.

AMED : 224.59 (+0.24%)
Amedisys to Present at the Baird 2020 Global Healthcare Conference

Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer will present at the...

AMED : 224.59 (+0.24%)
Shares of AMED Up 28.6% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Amedisys Inc (NASDAQ:AMED) on June 18th, 2020 at $185.42. In approximately 2 months, Amedisys Inc has returned 28.55% as of today's recent price of $238.36.

AMED : 224.59 (+0.24%)
Amedisys & BrightStar Ink Agreement to Expand Personal Care

Amedisys (AMED) strengthens Personal Care business reach by entering into an agreement with BrightStar.

AMED : 224.59 (+0.24%)
HOLX : 63.01 (-1.16%)
QGEN : 51.17 (+0.87%)
TMO : 418.14 (-0.62%)
Amedisys Expands Personal Care Network with BrightStar Care

Amedisys, Inc. (NASDAQ: AMED), America's leading independent home health, hospice and personal care company, has signed a Care Coordination Agreement with BrightStar Care to add its agencies to the Amedisys...

AMED : 224.59 (+0.24%)
Amedisys Inc Set to Possibly Pullback After Yesterday's Rally of 1.23%

Amedisys Inc (NASDAQ:AMED) traded in a range yesterday that spanned from a low of $236.18 to a high of $239.84. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of...

AMED : 224.59 (+0.24%)
Amedisys Banks on Coronavirus-Driven Growth Amid Cost Woes

Amedisys (AMED) has been benefiting from the recent acquisitions of hospice care providers.

AMED : 224.59 (+0.24%)
HOLX : 63.01 (-1.16%)
QGEN : 51.17 (+0.87%)
TMO : 418.14 (-0.62%)
Amedisys Rides on Hospice Arm Expansion Amid Coronavirus Woes

Amedisys (AMED) benefits from the recent acquisitions of hospice care providers, Asana Hospice, RoseRock Healthcare and Compassionate Care Hospice.

AMED : 224.59 (+0.24%)
DGX : 109.19 (-1.91%)
HOLX : 63.01 (-1.16%)
QGEN : 51.17 (+0.87%)
DGX vs. AMED: Which Stock Is the Better Value Option?

DGX vs. AMED: Which Stock Is the Better Value Option?

DGX : 109.19 (-1.91%)
AMED : 224.59 (+0.24%)
Amedisys to Present at the BMO 2020 Prescriptions for Success Healthcare Conference

Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer will present at the...

AMED : 224.59 (+0.24%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade AMED with:

Business Summary

Amedisys, Inc. is a leading provider of healthcare in the home with a vision of becoming the premiere solution for patients. From home health to hospice to personal care, Amedisys team members provide quality, clinically-distinctive care to patients every year. Amedisys is focused on delivering the care...

See More

Key Turning Points

2nd Resistance Point 233.26
1st Resistance Point 228.93
Last Price 224.59
1st Support Level 221.02
2nd Support Level 217.44

See More

52-Week High 248.96
Last Price 224.59
Fibonacci 61.8% 200.08
Fibonacci 50% 184.98
Fibonacci 38.2% 169.88
52-Week Low 121.00

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar